Analgesics Market to Grow at 6.2% CAGR by 2035

The rising number of various acute and chronic diseases such as cancer, arthritis, and cardiovascular diseases drives the analgesics market growth.

According to a new research report by Next Move Strategy Consulting, the global analgesics market was valued at USD 48.5 billion in 2025 and is expected to reach USD 51.5 billion in 2026. Sustained demand for pain relief across aging global populations, rising chronic disease prevalence, and expanding access to over-the-counter (OTC) medications are projected to propel the market to USD 89.0 billion by 2035, advancing at a CAGR of 6.2% from 2026 to 2035.

Analgesics have been witnessing rapid growth in sales due to the growing number of patients suffering from infectious diseases such as gastrointestinal disorders, respiratory problems, and neural disorders. Surge in these diseases boosts the demand for painkillers, which in turn drives the analgesics market growth. Furthermore, rising prevalence of cardiovascular diseases and cancer has also increased the demand for analgesics, especially opioid drugs.

On the contrary, factors such as drug abuse, growing use of biologics for the treatment of inflammatory pain, and stringent regulatory policies are hampering the analgesics industry to some extent. However, the analgesics industry will benefit from increased demand for personalized medicine and development of new pain-relieving drugs in the upcoming years.

Stay ahead in the Electric Shaver Market! Access the latest market trends and in-depth analysis with our exclusive report. Request a Free Sample Now

According to the report, the leading market players in the analgesics market include Haleon plc, Kenvue Inc., Bayer AG, Reckitt Benckiser Group plc, Opella Healthcare Group SAS, Perrigo Company plc, Grunenthal GmbH, Hisamitsu Pharmaceutical Co., Inc., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., Viatris Inc., Sandoz Group AG, Dr. Reddy's Laboratories Limited, Cipla Limited, Lupin Limited, Hikma Pharmaceuticals PLC, Alkem Laboratories Limited, Pacira BioSciences, Inc., Collegium Pharmaceutical, Inc., Keenova Therapeutics plc.

Key Insights from the Analgesics Market Report:

• The information related to key drivers, restraints, and opportunities and their impact on the analgesics market is provided in the report.

• Value chain analysis in the market study provides a clear picture of the stakeholders’ roles.

• The market share of the players in the global analgesics market along with their competitive analysis is provided in the report.

About Next Move Strategy Consulting

Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solutions that range from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.

For more insights, browse reports